We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.37B
AUM Growth
+$62.8M
Cap. Flow
-$112M
Cap. Flow %
-2.09%
Top 10 Hldgs %
20.35%
Holding
855
New
121
Increased
189
Reduced
310
Closed
120

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$45.7M
2
IDXX icon
Idexx Laboratories
IDXX
+$34.3M
3
CAH icon
Cardinal Health
CAH
+$30.2M
4
AMAT icon
Applied Materials
AMAT
+$24.5M
5
ELV icon
Elevance Health
ELV
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 18.73%
2 Financials 15.53%
3 Industrials 13.23%
4 Consumer Discretionary 12.83%
5 Technology 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTSH icon
76
Cognizant
CTSH
$28.7B
$19.1M 0.36%
362,217
+49,525
+16% +$2.47M
TRIP icon
77
TripAdvisor
TRIP
$1.15B
$18.8M 0.35%
251,973
+124,193
+97% +$9.69M
EQM
78
DELISTED
EQM Midstream Partners, LP
EQM
$18.4M 0.34%
209,334
-80,763
-28% -$6.97M
URI icon
79
United Rentals
URI
$64.6B
$17.5M 0.33%
171,284
-113,491
-40% -$12.2M
BDX icon
80
Becton Dickinson
BDX
$51.2B
$16.9M 0.32%
124,663
+98,742
+381% +$12.6M
PAA icon
81
Plains All American Pipeline
PAA
$18B
$16.9M 0.31%
328,378
-13,633
-4% -$724K
EWBC icon
82
East-West Bancorp
EWBC
$17.8B
$16.5M 0.31%
+425,815
New +$15.4M
CBOE icon
83
Cboe Global Markets
CBOE
$32.8B
$14.5M 0.27%
228,348
-751
-0.3% -$44.8K
PCP
84
DELISTED
PRECISION CASTPARTS CORP
PCP
$14.2M 0.26%
58,751
+3,489
+6% +$805K
KLXI
85
DELISTED
KLX Inc.
KLXI
$13.7M 0.26%
+394,405
New +$13.9M
HCA icon
86
HCA Healthcare
HCA
$90.8B
$13.4M 0.25%
182,141
+114,961
+171% +$8.08M
ETP
87
DELISTED
Energy Transfer Partners, L.P.
ETP
$12.5M 0.23%
299,641
-44,785
-13% -$2.06M
V icon
88
Visa
V
$709B
$12.4M 0.23%
188,724
+11,808
+7% +$711K
SMCI icon
89
Super Micro Computer
SMCI
$24.9B
$12M 0.22%
+3,431,670
New +$10.7M
ARMH
90
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$11.7M 0.22%
252,361
+97,229
+63% +$4.15M
BRK.B icon
91
Berkshire Hathaway Class B
BRK.B
$1.08T
$10.9M 0.2%
72,556
+546
+0.8% +$78.8K
AGN
92
DELISTED
Allergan plc
AGN
$10.8M 0.2%
41,880
+38,171
+1,029% +$9.54M
OKE icon
93
Oneok
OKE
$59.7B
$9.86M 0.18%
198,023
+666
+0.3% +$36.8K
MCO icon
94
Moody's
MCO
$88.2B
$9.66M 0.18%
100,858
+6,025
+6% +$584K
XOM icon
95
ExxonMobil
XOM
$643B
$9.54M 0.18%
103,212
-859
-0.8% -$80.1K
TRGP icon
96
Targa Resources
TRGP
$62B
$9.54M 0.18%
89,951
-23,982
-21% -$2.78M
HDB icon
97
HDFC Bank
HDB
$115B
$8.97M 0.17%
707,340
+37,936
+6% +$479K
PG icon
98
Procter & Gamble
PG
$333B
$8.77M 0.16%
96,324
-6,504
-6% -$572K
DHR icon
99
Danaher
DHR
$152B
$8.74M 0.16%
151,659
-2,413
-2% -$131K
IJR icon
100
iShares Core S&P Small-Cap ETF
IJR
$111B
$7.86M 0.15%
137,834
+3,472
+3% +$190K

Similar funds

Geneva Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Geneva Advisors held 855 positions worth $5.37B, up 1.2% from $5.31B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneva Advisors's Q4 2014 filing shows 121 new, 189 increased, 310 reduced and 120 closed positions. Its largest new stake was Idexx Laboratories: 488,650 shares worth $36.2M. The largest sale was LyondellBasell Industries, an estimated $73.1M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q4 2014 buy was Idexx Laboratories: 488,650 shares worth $36.2M.
  • Geneva Advisors added most to Alibaba in Q4 2014, an estimated $45.7M increase.
  • Geneva Advisors's biggest Q4 2014 reduction was LyondellBasell Industries, cutting an estimated $73.1M.
  • Geneva Advisors fully exited Community Health Systems in Q4 2014, selling an estimated $13M.
  • Geneva Advisors's ten largest holdings make up 20% of its $5.37B portfolio in Q4 2014.
  • Geneva Advisors opened 121 new positions and closed 120 in Q4 2014.
  • Geneva Advisors's portfolio value rose 1.2% quarter-over-quarter to $5.37B.

Based on Geneva Advisors's 13F filing for Q4 2014, filed 2 Feb 2015.